Commenters split on FDA’s off-label communication guidance
Regulatory NewsMary Ellen Schneider
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsUnited StatesRegulatory NewsMary Ellen SchneiderAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsUnited States